| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10025310 | HBV | ENSG00000244067.3 | protein_coding | GSTA2 | No | No | 2939 | A0A140VKE2 P09210 |
| TVIS10059881 | HBV | ENSG00000244067.3 | protein_coding | GSTA2 | No | No | 2939 | A0A140VKE2 P09210 |
| TVIS10059883 | HBV | ENSG00000244067.3 | protein_coding | GSTA2 | No | No | 2939 | A0A140VKE2 P09210 |
| TVIS10059885 | HBV | ENSG00000244067.3 | protein_coding | GSTA2 | No | No | 2939 | A0A140VKE2 P09210 |
| TVIS10059884 | HBV | ENSG00000244067.3 | protein_coding | GSTA2 | No | No | 2939 | A0A140VKE2 P09210 |
| TVIS10059882 | HBV | ENSG00000244067.3 | protein_coding | GSTA2 | No | No | 2939 | A0A140VKE2 P09210 |
| TVIS10059886 | HBV | ENSG00000244067.3 | protein_coding | GSTA2 | No | No | 2939 | A0A140VKE2 P09210 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GSTA2 |
|---|---|
| DrugBank ID | DB00143 |
| Drug Name | Glutathione |
| Target ID | BE0002189 |
| UniProt ID | P09210 |
| Regulation Type | |
| PubMed IDs | 17317527; 17321661; 17338280; 17338281; 17401685 |
| Citations | Sharma P, Ahmad Shah Z, Kumar A, Islam F, Mishra KP: Role of combined administration of Tiron and glutathione against aluminum-induced oxidative stress in rat brain. J Trace Elem Med Biol. 2007;21(1):63-70. Epub 2007 Feb 6.@@Skamarauskas J, Carter W, Fowler M, Madjd A, Lister T, Mavroudis G, Ray DE: The selective neurotoxicity produced by 3-chloropropanediol in the rat is not a result of energy deprivation. Toxicology. 2007 Apr 11;232(3):268-76. Epub 2007 Jan 21.@@Ozkilic AC, Cengiz M, Ozaydin A, Cobanoglu A, Kanigur G: The role of N-acetylcysteine treatment on anti-oxidative status in patients with type II diabetes mellitus. J Basic Clin Physiol Pharmacol. 2006;17(4):245-54.@@Guruvayoorappan C, Afira AH, Kuttan G: Antioxidant potential of Biophytum sensitivum extract in vitro and in vivo. J Basic Clin Physiol Pharmacol. 2006;17(4):255-67.@@Gupta S, Sarotra P, Aggarwal R, Dutta N, Agnihotri N: Role of oxidative stress in celecoxib-induced renal damage in wistar rats. Dig Dis Sci. 2007 Nov;52(11):3092-8. Epub 2007 Mar 31. |
| Groups | Approved; Investigational; Nutraceutical |
| Direct Classification | Peptides |
| SMILES | N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O |
| Pathways | Arachidonic Acid Metabolism; Flurbiprofen Action Pathway; 4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency; Oxaprozin Action Pathway; Rofecoxib Action Pathway; Pyruvate Kinase Deficiency; Acetaminophen Metabolism Pathway; Mefenamic Acid Action Pathway; Bromfenac Action Pathway; 5-Oxoprolinuria; gamma-Glutamyltransferase Deficiency; Naproxen Action Pathway; Sulindac Action Pathway; Glutathione Synthetase Deficiency; Piroxicam Action Pathway; Nabumetone Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); Meloxicam Action Pathway; Cyclophosphamide Action Pathway; Succinic Semialdehyde Dehydrogenase Deficiency; Valdecoxib Action Pathway; Ketorolac Action Pathway; 5-Oxoprolinase Deficiency; Acetylsalicylic Acid Action Pathway; Antipyrine Action Pathway; Glutathione Metabolism; Diclofenac Action Pathway; Homocarnosinosis; Cyclophosphamide Metabolism Pathway; Nepafenac Action Pathway |
| PharmGKB | PA449780 |
| ChEMBL | CHEMBL1543 |
